Celadon Pharmaceuticals (CEL) News Today GBX 13.40 0.00 (0.00%) As of 08/6/2025 Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlinesBuy This Stock CEL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Celadon Pharmaceuticals Passes AGM Resolutions and Plans DelistingJuly 1, 2025 | tipranks.comAIM WINNERS & LOSERS: Celadon jumps; Frasers eyes Revolution BeautyJune 9, 2025 | lse.co.ukCeladon Pharmaceuticals Faces Financial Uncertainty Amid Funding EffortsJune 6, 2025 | tipranks.comCeladon Pharmaceuticals faces potential administrationJune 1, 2025 | investing.comCeladon Pharmaceuticals Faces Financial Uncertainty Amid Funding ChallengesMay 30, 2025 | tipranks.comCeladon Pharmaceuticals Terminates Credit Facility Amid Strategic Financial AdjustmentsApril 8, 2025 | tipranks.comCeladon Pharmaceuticals Faces Financial Uncertainty Amid Funding DelaysMarch 31, 2025 | tipranks.comAIM WINNERS & LOSERS: Insig AI projects 70% growth in fourth quarterMarch 24, 2025 | lse.co.ukCeladon Pharmaceuticals to Delist From AIMMarch 24, 2025 | marketwatch.comCeladon Pharmaceuticals Secures £1.95 Million Credit Facility to Boost GrowthFebruary 26, 2025 | tipranks.comCeladon Pharmaceuticals Updates on Financial PositionFebruary 12, 2025 | tipranks.comCeladon Pharmaceuticals Share Chat (CEL)January 18, 2025 | lse.co.ukAIM WINNERS & LOSERS: Deltex to cancel "onerous" AIM listingJanuary 16, 2025 | lse.co.ukCeladon Pharmaceuticals Provides Finance Update Ensuring Operational StabilityDecember 20, 2024 | tipranks.comTRADING UPDATES: SDX plots AIM exit; Celadon receives fundsDecember 6, 2024 | lse.co.ukAIM WINNERS & LOSERS: Judges Scientific down on "disappointing" tradeNovember 18, 2024 | lse.co.ukCeladon shares slump on little progress in financing talksNovember 18, 2024 | lse.co.ukCeladon Pharmaceuticals Faces Financial UncertaintiesNovember 18, 2024 | msn.comCeladon Pharmaceuticals PLC (LSE:CEL) (H1 2024) Earnings Call Highlights: Strategic ...October 10, 2024 | finance.yahoo.comCeladon Pharmaceuticals Plc (CEL.L)October 6, 2024 | finance.yahoo.comCeladon Pharmaceuticals signs sales contract with Valeos PharmaOctober 2, 2024 | lse.co.ukEXECUTIVE CHANGES: Bank of Ireland promotes ex-Barclays exec to chairSeptember 30, 2024 | lse.co.ukRocket Panda Brings New Adventure to the Genesis and Mega DriveSeptember 19, 2024 | msn.comCeladon Pharmaceuticals shares dive as laments delayed fundingSeptember 11, 2024 | lse.co.ukUK Cannabis Firm Raises £1.05M Via Discounted Offering, Expands Partnership With Danish Medical Marijuana ProducerSeptember 11, 2024 | benzinga.comAIM WINNERS & LOSERS: Global Petroleum jumps on potential Namibia dealAugust 12, 2024 | lse.co.ukCeladon Pharmaceutical shares dive amid delayed receipt of fundsAugust 12, 2024 | lse.co.ukTRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pactMay 23, 2024 | lse.co.ukCeladon Pharmaceuticals PLC CELFebruary 28, 2024 | morningstar.comMCeladon announces start of cannabis supply for two UK companiesDecember 14, 2023 | lse.co.ukTRADING UPDATES: Celadon Pharma raises GBP2.0 million via placingDecember 12, 2023 | lse.co.ukUK's First Medical Marijuana Clinical Trial Gets Underway: National Health Service Remains CautiousDecember 4, 2023 | msn.comCeladon shares rise on supply contract worth up to GBP26 millionNovember 16, 2023 | lse.co.ukCeladon Pharmaceuticals to Raise GBP1 Mln via Discounted Placing, SubscriptionOctober 13, 2023 | marketwatch.comCeladon Pharmaceuticals First Half 2023 Earnings: UK£0.07 loss per share (vs UK£0.25 loss in 1H 2022)October 1, 2023 | finance.yahoo.comCeladon Pharmaceuticals interim loss narrows; optimistic for futureSeptember 28, 2023 | lse.co.ukCeladon shares rise on second UK contract win for cannabis productSeptember 5, 2023 | lse.co.ukCeladon Pharmaceuticals Enters New Contract Worth Up to GBP1.2 Mln in RevenueSeptember 5, 2023 | marketwatch.comOwning 61% in Celadon Pharmaceuticals Plc (LON:CEL) means that insiders are heavily invested in the company's futureAugust 22, 2023 | finance.yahoo.comCEL.L - Celadon Pharmaceuticals PlcAugust 1, 2023 | ca.finance.yahoo.comCeladon receives approval for 5,000 patient clinical cannabis trialAugust 1, 2023 | lse.co.ukInvestors’ Chronicle: Oxford Metrics, N Brown, Celadon PharmaceuticalsJune 9, 2023 | finance.yahoo.comCeladon Pharmaceuticals loss widens; confident amid three-year dealJune 5, 2023 | lse.co.ukCeladon secures GBP7 million credit facility as product demand growsMay 30, 2023 | lse.co.ukCeladon Pharmaceuticals Shares Rise on New GBP7 Mln Line of CreditMay 30, 2023 | marketwatch.comCeladon signs commercial cannabis supply agreement with UK firmMay 24, 2023 | lse.co.ukCORRECT: Celadon signs commercial cannabis supply agreement in UKMay 24, 2023 | lse.co.ukC15 Solutions Anticipates Substantial Growth in European Cannabis Market Through Innovative Tech PlatformApril 20, 2023 | finance.yahoo.comJames Short Celadon Pharmaceuticals Plc's (LON:CEL) CEO is the most bullish insider, and their stock value gained 162%last weekMarch 15, 2023 | finance.yahoo.comFresh permit for cannabis lifts CeladonMarch 14, 2023 | thetimes.co.ukT Get Celadon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CEL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CEL Media Mentions By Week CEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CEL News Sentiment▼0.001.03▲Average Medical News Sentiment CEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CEL Articles This Week▼00▲CEL Articles Average Week Get the Latest News and Ratings for CEL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Celadon Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Beacon Energy News Today Fox Marble News Today Vodafone Group Public News Today BT Group News Today BBGI Global Infrastructure News Today Pacific Horizon Investment Trust News Today Chill Brands Group News Today Beximco Pharmaceuticals News Today Haleon News Today Hikma Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:CEL) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celadon Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Celadon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access